Literature DB >> 21420034

MicroRNAs in kidney function and disease.

Sanjeev Akkina1, Bryan N Becker.   

Abstract

MicroRNAs (miRNA) are short, noncoding RNA sequences that regulate gene expression by blocking protein translation or inducing messenger RNA (mRNA) degradation. miRNA is found in various tissues with variable expression, and changes in expression are related to various disease processes. Evidence suggests that changes in miRNA expression are critical for the normal development of kidney tissue. Alternatively, in diseases such as diabetic nephropathy, polycystic kidney disease, and lupus nephritis, specific miRNAs may enhance disease manifestations in a myriad of ways, ranging from activation of fibrotic pathways to anatomic changes that abet proteinuria. The variable expression of miRNA in kidney tissue, whether in the context of normal development or disease processes, makes miRNAs a valuable new tool for understanding, diagnosing, and discovering therapeutic options for pathologic processes that affect the kidney.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420034      PMCID: PMC3062898          DOI: 10.1016/j.trsl.2011.01.011

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  38 in total

1.  Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs.

Authors:  Yingqing Sun; Seongjoon Koo; Neill White; Eigen Peralta; Christine Esau; Nicholas M Dean; Ranjan J Perera
Journal:  Nucleic Acids Res       Date:  2004-12-22       Impact factor: 16.971

2.  Silencing of microRNAs in vivo with 'antagomirs'.

Authors:  Jan Krützfeldt; Nikolaus Rajewsky; Ravi Braich; Kallanthottathil G Rajeev; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nature       Date:  2005-10-30       Impact factor: 49.962

3.  An optimized isolation and labeling platform for accurate microRNA expression profiling.

Authors:  Jaclyn Shingara; Kerri Keiger; Jeffrey Shelton; Walairat Laosinchai-Wolf; Patricia Powers; Richard Conrad; David Brown; Emmanuel Labourier
Journal:  RNA       Date:  2005-07-25       Impact factor: 4.942

Review 4.  Genomics of microRNA.

Authors:  V Narry Kim; Jin-Wu Nam
Journal:  Trends Genet       Date:  2006-01-30       Impact factor: 11.639

5.  miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs.

Authors:  Zissimos Mourelatos; Josée Dostie; Sergey Paushkin; Anup Sharma; Bernard Charroux; Linda Abel; Juri Rappsilber; Matthias Mann; Gideon Dreyfuss
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

6.  Identification of a novel polymorphism in the 3'UTR of the L-arginine transporter gene SLC7A1: contribution to hypertension and endothelial dysfunction.

Authors:  Zhiyong Yang; Kylie Venardos; Emma Jones; Brian J Morris; Jaye Chin-Dusting; David M Kaye
Journal:  Circulation       Date:  2007-02-26       Impact factor: 29.690

7.  MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts.

Authors:  Mickey M Martin; Eun Joo Lee; Jessica A Buckenberger; Thomas D Schmittgen; Terry S Elton
Journal:  J Biol Chem       Date:  2006-05-04       Impact factor: 5.157

8.  A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer.

Authors:  Merle Hanke; Kai Hoefig; Hartmut Merz; Alfred C Feller; Ingo Kausch; Dieter Jocham; Jens M Warnecke; Georg Sczakiel
Journal:  Urol Oncol       Date:  2009-04-17       Impact factor: 3.498

9.  MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.

Authors:  Mitsuo Kato; Jane Zhang; Mei Wang; Linda Lanting; Hang Yuan; John J Rossi; Rama Natarajan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

10.  Clustering and conservation patterns of human microRNAs.

Authors:  Yael Altuvia; Pablo Landgraf; Gila Lithwick; Naama Elefant; Sébastien Pfeffer; Alexei Aravin; Michael J Brownstein; Thomas Tuschl; Hanah Margalit
Journal:  Nucleic Acids Res       Date:  2005-05-12       Impact factor: 16.971

View more
  18 in total

1.  MicroRNAs: miRRORS of health and disease.

Authors:  Monty Montano
Journal:  Transl Res       Date:  2011-02-11       Impact factor: 7.012

Review 2.  Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Authors:  Salvador Lopez-Giacoman; Magdalena Madero
Journal:  World J Nephrol       Date:  2015-02-06

Review 3.  The ureteric bud epithelium: morphogenesis and roles in metanephric kidney patterning.

Authors:  Vidya K Nagalakshmi; Jing Yu
Journal:  Mol Reprod Dev       Date:  2015-03-17       Impact factor: 2.609

4.  The relationship between amniotic fluid miRNAs and congenital obstructive nephropathy.

Authors:  Juntao Xie; Yi Zhou; Wenzong Gao; Zuoqing Li; Zhe Xu; Li Zhou
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

5.  Mesenchymal Stem Cells Alleviate Renal Fibrosis and Inhibit Autophagy via Exosome Transfer of miRNA-122a.

Authors:  Dawei Li; Junwen Qu; Xiaodong Yuan; Shaoyong Zhuang; Haoyu Wu; Ruoyang Chen; Jiajin Wu; Ming Zhang; Liang Ying
Journal:  Stem Cells Int       Date:  2022-07-07       Impact factor: 5.131

6.  Renal epithelial miR-205 expression correlates with disease severity in a mouse model of congenital obstructive nephropathy.

Authors:  Michael E Wilhide; James D Feller; Birong Li; Ahmad Z Mohamed; Brian Becknell; Ashley R Jackson; Kirk M McHugh; Susan E Ingraham
Journal:  Pediatr Res       Date:  2016-06-07       Impact factor: 3.756

7.  Novel susceptibility locus at 22q11 for diabetic nephropathy in type 1 diabetes.

Authors:  Maija Wessman; Carol Forsblom; Mari A Kaunisto; Jenny Söderlund; Jorma Ilonen; Riitta Sallinen; Tero Hiekkalinna; Maija Parkkonen; Alexander P Maxwell; Lise Tarnow; Hans-Henrik Parving; Samy Hadjadj; Michel Marre; Leena Peltonen; Per-Henrik Groop
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

8.  Increased circulating miR-21 levels are associated with kidney fibrosis.

Authors:  François Glowacki; Grégoire Savary; Viviane Gnemmi; David Buob; Cynthia Van der Hauwaert; Jean-Marc Lo-Guidice; Sébastien Bouyé; Marc Hazzan; Nicolas Pottier; Michaël Perrais; Sébastien Aubert; Christelle Cauffiez
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

9.  The role of viral and host microRNAs in the Aujeszky's disease virus during the infection process.

Authors:  Oriol Timoneda; Fernando Núñez-Hernández; Ingrid Balcells; Marta Muñoz; Anna Castelló; Gonzalo Vera; Lester J Pérez; Raquel Egea; Gisela Mir; Sarai Córdoba; Rosa Rosell; Joaquim Segalés; Anna Tomàs; Armand Sánchez; José I Núñez
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

10.  Proteogenomics of selective susceptibility to endotoxin using circulating acute phase biomarkers and bioassay development in sheep: a review.

Authors:  Saul Chemonges; John-Paul Tung; John F Fraser
Journal:  Proteome Sci       Date:  2014-03-01       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.